These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38302875)

  • 1. A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer.
    Rade M; Kreuz M; Borkowetz A; Sommer U; Blumert C; Füssel S; Bertram C; Löffler D; Otto DJ; Wöller LA; Schimmelpfennig C; Köhl U; Gottschling AC; Hönscheid P; Baretton GB; Wirth M; Thomas C; Horn F; Reiche K
    Mol Med; 2024 Feb; 30(1):19. PubMed ID: 38302875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer.
    Kreuz M; Otto DJ; Fuessel S; Blumert C; Bertram C; Bartsch S; Loeffler D; Puppel SH; Rade M; Buschmann T; Christ S; Erdmann K; Friedrich M; Froehner M; Muders MH; Schreiber S; Specht M; Toma MI; Benigni F; Freschi M; Gandaglia G; Briganti A; Baretton GB; Loeffler M; Hackermüller J; Reiche K; Wirth M; Horn F
    Eur Urol; 2020 Sep; 78(3):452-459. PubMed ID: 32631745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
    Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
    Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.
    Scott DW; Abrisqueta P; Wright GW; Slack GW; Mottok A; Villa D; Jares P; Rauert-Wunderlich H; Royo C; Clot G; Pinyol M; Boyle M; Chan FC; Braziel RM; Chan WC; Weisenburger DD; Cook JR; Greiner TC; Fu K; Ott G; Delabie J; Smeland EB; Holte H; Jaffe ES; Steidl C; Connors JM; Gascoyne RD; Rosenwald A; Staudt LM; Campo E; Rimsza LM;
    J Clin Oncol; 2017 May; 35(15):1668-1677. PubMed ID: 28291392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.
    Chen R; Guan Q; Cheng J; He J; Liu H; Cai H; Hong G; Zhang J; Li N; Ao L; Guo Z
    Oncotarget; 2017 Jan; 8(4):6652-6662. PubMed ID: 28036264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
    Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
    Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.
    Nonn L; Vaishnav A; Gallagher L; Gann PH
    Exp Mol Pathol; 2010 Feb; 88(1):45-51. PubMed ID: 19874819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
    Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
    BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
    Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
    JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative molecular profiling of routine clinical prostate cancer specimens.
    Grasso CS; Cani AK; Hovelson DH; Quist MJ; Douville NJ; Yadati V; Amin AM; Nelson PS; Betz BL; Liu CJ; Knudsen KE; Cooney KA; Feng FY; McDaniel AS; Tomlins SA
    Ann Oncol; 2015 Jun; 26(6):1110-1118. PubMed ID: 25735316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material.
    Peng Z; Andersson K; Lindholm J; Dethlefsen O; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
    PLoS One; 2016; 11(1):e0145545. PubMed ID: 26731648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
    Li P; Conley A; Zhang H; Kim HL
    BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
    Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
    Tyekucheva S; Martin NE; Stack EC; Wei W; Vathipadiekal V; Waldron L; Fiorentino M; Lis RT; Stampfer MJ; Loda M; Parmigiani G; Mucci LA; Birrer M
    J Mol Diagn; 2015 Jul; 17(4):374-81. PubMed ID: 25937617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of transcript profiling in formalin-fixed paraffin-embedded diagnostic prostate cancer needle biopsies.
    Rogerson L; Darby S; Jabbar T; Mathers ME; Leung HY; Robson CN; Sahadevan K; O'Toole K; Gnanapragasam VJ
    BJU Int; 2008 Aug; 102(3):364-70. PubMed ID: 18410440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression signatures that correlated with Gleason score and relapse in prostate cancer.
    Bibikova M; Chudin E; Arsanjani A; Zhou L; Garcia EW; Modder J; Kostelec M; Barker D; Downs T; Fan JB; Wang-Rodriguez J
    Genomics; 2007 Jun; 89(6):666-72. PubMed ID: 17459658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.